MedPath

Investigating dialectical drug therapy on reducing impulsivity in men with comorbid borderline personality disorder and substance abuse

Not Applicable
Conditions
impulsiveness.
Other impulse disorders
F63.8
Registration Number
IRCT20230806059058N1
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
30
Inclusion Criteria

All people with borderline personality disorder
Taking any kind of drugs for more than 6 months

Exclusion Criteria

Taking psychiatric drugs
History of psychiatric interventions over the past years
Physical illness (diabetes, blood pressure, cardiovascular disease)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Impulsivity. Timepoint: En The beginning of the study (before the start of the intervention) and the end of the study (after the end of the intervention) 45 days later. Method of measurement: Impulsivity questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath